Health Screening Market is Probable to Influence the Value of USD 6,09,134 Million by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Analysis

Data Bridge Market Research analyses that the health screening market was valued at USD 2,11,225.2 m

 | Source: Data Bridge Market Research Data Bridge Market Research

NEW YORK, May 10, 2023 (GLOBE NEWSWIRE) -- The newest report from Data Bridge Market Research, "Health Screening Market" examines growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and the competitive environment in detail. The persuasive Health Screening report helps businesses in knowing its market share over various time periods, the transportation, storage, and supply requirements of its products. This market report serves to be an ideal solution for a better understanding of the market. It is helpful in finding out the size of the market for specific products. The report gives helpful insights which assist while launching a new product. The market study aids in making sales forecasts for its products and thereby, establishing harmonious adjustment between demand and supply of its products. An international Health Screening market report helps the firm in exploring new uses and new markets for its existing products and thereby, increasing the demand for its products.

The steadfast Health Screening market report offers sustainable forward-looking growth programs, to ensure business success which is imperative for organizations. With this report businesses can create a unique space in the global industry and get identified as the most consistent and dedicated growth partner for market research, strategy formulation and sustainable organizational development. While formulating this report, client business competence is understood adeptly to identify tangible growth opportunities. Moreover, the strategic model around the growth objective is designed by analysts, with a detailed route-to-market analysis, competencies to be leveraged and developed, as well as any potential pitfalls.

Data Bridge Market Research analyses that the health screening market was valued at USD 2,11,225.2 million in 2021 and is expected to reach USD 6,09,134 million by 2029, registering a CAGR of 12.4% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework

Get a Sample PDF of the Health Screening Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-health-screening-market

Health screening is an important tool for detecting a disease early on. Screening tests are frequently used in preventative medicine to determine whether a person displays early indicators of a condition's risk factors. Cancer, diabetes, high cholesterol, high blood pressure, and osteoporosis are all diseases that can be discovered by screening.

The market for health screening is estimated to increase rapidly over the forecast period. According to a study conducted by the University of Utah GSLC, researchers were able to achieve telomerase activity inhibition in prostate and breast cancer cells cultivated in the lab, resulting in tumor cell death. As a result of these studies, telomere test kits in cellular health screening and other applications have increased, which is projected to boost the health screening market in the forecast years. Hence, an increase in the frequency of chronic diseases and an increase in the geriatric population has resulted in the high demand for health screening in the market.

The Latest Study Conducts a Comprehensive Analysis of the Global Market, considering the current competitive landscape and its future evolution in the next few years.

The global Health Screening market is experiencing rapid growth, fueled by rising demands, industrialization, consumer awareness, and technological advancements. Sales and revenue in this sector have surged at an exponential pace, and the market's expansion is expected to continue over the projected period.

In order to expand their market share and reach a wider client base, leading businesses in the worldwide Health Screening market are heavily investing in research and development. The study provides detailed insights into the strategies, financial health, revenue, gross margin, and growth rates of these companies.

Recent Development

  • In November 2021, Evoq Technologies LLC had announced the launch of first smartphone-based product for retinal health testing. The "SmartERG" Platform is designed to assess the retinal health of the eye in novel ways. With the force multipliers of simple patient-provider connection, cloud-based analytical services, and a great fit for artificial intelligence, the SmartERG Platform will offer a breakthrough delivery approach for ophthalmic patient care.
  • In September 2021, Eurofins Scientific SE’s subsidiary Transplant Genomics had announced the launch of OmniGraf. It combines the Viracor TRAC donor-derived cell-free DNA assays with the TruGraf blood gene expression test. OmniGraf Kidney is the first diagnostic tool for renal transplant recipients that integrates cell-free DNA and gene expression data. When paired with TGI's unique technology and machine learning, the test provides patients with the most accurate and timely assessment of kidney transplant rejection.

Opportunities

  • Technological advancement   

Moreover, the rising adoption rate of advanced technologies will provide beneficial opportunities for the health screening market growth.  

Moreover, growing number of service providers and increase in the number of emerging markets will further provide beneficial opportunities for the health screening market growth during the forecast period.

The most prominent players in the Health Screening market include.

  • Quest Diagnostics Incorporated (US)
  • GRAIL(US)
  • Eurofins Scientific (Luxembourg)
  • Exact Sciences Corporation (US)
  • SYNLAB International GmbH (Germany)
  • UNILABS (Switzerland)
  • LabPLUS (US)
  • BioReference Laboratories (US)
  • Sonic Healthcare Limited (Australia)
  • ACM Global Laboratories (NY)
  • Cerba Healthcare (France)
  • Quidel Corporation (US)
  • Innova Medical Group (US)
  • Amedes Holding GmbH (Germany)
  • RadNet, Inc. (US)
  • Natera, Inc. (US)
  • Trinity Biotech (Ireland)
  • Nuffield Health (UK)
  • RepeatDx (Canada)
  • NeoGenomics Laboratories (US)
  • H.U Group Holdings, Inc. (Japan)
  • ARUP Laboratories (US)
  • Q2 Solutions (US)
  • Genova Diagnostics (US)

Click Here to Download the Complete Research Study in PDF Format @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-health-screening-market

Our market intelligence platform provides a range of benefits that will help you gain valuable insights and stay ahead in the market. By utilizing our platform, you can:

  • Identify emerging market trends and dynamics
  • Access high-quality and accurate market intelligence
  • Benchmark your performance against competitors and industry standards
  • Explore competitive strategies and analyze market share
  • Discover regional market opportunities that may have been overlooked
  • Choose from multiple deliverable formats, including PDF, PPT, Excel, and an online dashboard

With our comprehensive market intelligence platform, you can easily access the information you need to make informed decisions and stay ahead of the competition.

At Data Bridge Market Research, we employ a comprehensive and iterative research methodology aimed at minimizing deviations to provide the most accurate estimates and forecasts possible. Our approach involves utilizing both bottom-up and top-down methods to segment and estimate the quantitative aspects of the market. Furthermore, a recurring theme across all our research reports is data triangulation, which examines the market from three distinct perspectives.

To derive our market estimates and forecasts, we employ simulation models that are tailored for each study. We gather information on market dynamics, technology landscape, application development, and pricing trends, which are then fed into the model and analyzed simultaneously. We compare these factors and quantify their impact on the forecast period using correlation, regression, and time series analysis. Our market forecasting is performed using a combination of economic tools, technological analysis, and our team's industry experience and domain expertise.

Key Market Segments Covered in Health Screening Industry Research

Test Type

  • Cholesterol Tests
  • Diabetes Test
  • General Check-Up Test
  • STDs
  • Blood Pressure Test

Package Type

  • Basic Health Screening
  • Senior Citizen Profile
  • Women Health Check
  • Men Health Check
  • Heart Check
  • Diabetes Check

Panel Type

  • Multi-Test Panels
  • Single-Test Panels

Sample Type

  • Blood
  • Urine
  • Serum
  • Saliva

Technology

  • Immunoassays
  • QPCR (Quantitative Polymerase Chain Reaction)
  • Q-FISH (Quantitative Fluorescence, in Situ Hybridization)
  • TRF (Terminal Restriction Fragment)
  • STELA (Single Telomere Length Analysis)

Condition

  • Cardiovascular Disease
  • Metabolic Disorders
  • Cancer
  • Inflammatory Conditions
  • Musculoskeletal Disorders
  • Neurological Conditions
  • Hepatitis-C Complications
  • Immunology-Related Conditions

Sample Collection Sites

  • Hospital
  • Homes
  • Diagnostic Laboratories
  • Offices

Distribution Channel

  • Direct Tenders
  • Retail Sales

Explore Further Details about This Research Report @ https://www.databridgemarketresearch.com/reports/global-health-screening-market

Key Industry Drivers:

  • Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases such as diabetes, high blood pressure, cancer, high cholesterol, and osteoporosis will propel the market’s growth rate during the forecast period of 2022-2029.

  • Rise in the number of geriatric population

The number of persons aged 60 and up has consistently increased over time as a result of rising life expectancy. The worldwide geriatric population will grow from 727 million in 2020 to 1.5 billion by 2050, according to the United Nations Database on World Population Ageing 2020. Geriatric people are the highest risk of suffering from chronic diseases, increasing the demand for the health screening market.

Furthermore, the rising awareness about early detection and treatment of disease will be a major factor influencing the growth of the health screening market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the health screening market. Also, increasing expenditure on healthcare infrastructure and the continuously changing lifestyle of people are the major market drivers that will further escalate the growth of health screening market.

Health Screening Market Regional Analysis/Insights:

The countries covered in the health screening market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the health screening market because of the presence of a well-established healthcare sector and development of advanced technology in this region. Additionally, growing presence of major market players will flourish the market’s growth rate in this region. 

Asia-Pacific is expected to grow during the forecast period due to the rising prevalence of chronic diseases and the increasing number of geriatric populations in this region.

Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors

  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Executive Summary
  4. Premium Insights
  5. Global Health Screening Market: Regulations
  6. Market Overview
  7. Global Health Screening Market, By Test Type
  8. Global Health Screening Market, By Package Type
  9. Global Health Screening Market, By Panel Type
  10. Global Health Screening Market, By Sample Type
  11. Global Health Screening Market, By Technology
  12. Global Health Screening Market, By Sample Collection Sites
  13. Global Health Screening Market, By Distribution Channel
  14. Global Health Screening Market, By Region
  15. Global Health Screening Market: Company Landscape
  16. SWOT Analyses
  17. Company Profile
  18. Questionnaires
  19. Related Reports

Download the Complete Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-health-screening-market

Explore More Reports:

  • Europe Health Screening Market, By Test Type (Cholesterol Tests, Diabetes Test, Cancer Screening, General Check Up Test, STDs, Blood Pressure Test and Others), Package Type (Basic Health Screening, Senior Citizen Profile, Women Health Check, Men Health Check, Heart Check, Diabetes Check and Others), Panel Type (Multi-Test Panels and Single-Test Panels), Sample Type (Blood, Urine, Serum, Saliva and Others), Technology (Immunoassays, Medical Imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis) and Others), Condition (Cardiovascular Disease, Metabolic Disorders, Cancer, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions and Others), Sample Collection Sites (Hospital, Homes, Diagnostic Laboratories, Offices and Others), Distribution Channel (Direct Tenders, Retail Sales and Others), Country (Germany, France, U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe) https://www.databridgemarketresearch.com/reports/europe-health-screening-market
  • Asia-Pacific Health Screening Market, By Test Type (Cholesterol Tests, Diabetes Test, Cancer Screening, General Check Up Test, STDs, Blood Pressure Test and Others), Package Type (Basic Health Screening, Senior Citizen Profile, Women Health Check, Men Health Check, Heart Check, Diabetes Check and Others), Panel Type (Multi-Test Panels and Single-Test Panels), Sample Type (Blood, Urine, Serum, Saliva and Others), Technology (Immunoassays, Medical Imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis) and Others), Condition (Cardiovascular Disease, Metabolic Disorders, Cancer, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions and Others), Sample Collection Sites (Hospital, Homes, Diagnostic Laboratories, Offices and Others), Distribution Channel (Direct Tenders, Retail Sales and Others), Country (Japan,  China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific) https://www.databridgemarketresearch.com/reports/asia-pacific-health-screening-market
  • North America Health Screening Market, By Test Type (Cholesterol Tests, Diabetes Test, Cancer Screening, General Check Up Test, STDs, Blood Pressure Test and Others), Package Type (Basic Health Screening, Senior Citizen Profile, Women Health Check, Men Health Check, Heart Check, Diabetes Check and Others), Panel Type (Multi-Test Panels and Single-Test Panels), Sample Type (Blood, Urine, Serum, Saliva and Others), Technology (Immunoassays, Medical Imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis) and Others), Condition (Cardiovascular Disease, Metabolic Disorders, Cancer, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions and Others), Sample Collection Sites (Hospital, Homes, Diagnostic Laboratories, Offices and Others), Distribution Channel (Direct Tenders, Retail Sales and Others), Country (U.S., Canada & Mexico) https://www.databridgemarketresearch.com/reports/north-america-health-screening-market
  • Middle East and Africa Health Screening Market, By Test Type (Cholesterol Tests, Diabetes Test, Cancer Screening, General Check Up Test, STDs, Blood Pressure Test and Others), Package Type (Basic Health Screening, Senior Citizen Profile, Women Health Check, Men Health Check, Heart Check, Diabetes Check and Others), Panel Type (Multi-Test Panels and Single-Test Panels), Sample Type (Blood, Urine, Serum, Saliva and Others), Technology (Immunoassays, Medical Imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis) and Others), Condition (Cardiovascular Disease, Metabolic Disorders, Cancer, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions and Others), Sample Collection Sites (Hospital, Homes, Diagnostic Laboratories, Offices and Others), Distribution Channel (Direct Tenders, Retail Sales and Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel and Rest of the Middle East and Africa) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-health-screening-market
  • Metabolic Testing Market, By Product (CPET Systems, Metabolic Carts, ECG and EKG Systems, Body Composition Analyzers, Software), Application (Lifestyle Diseases, Critical Care, Human Performance Testing, Dysmetabolic Syndrome X, Metabolic Disorders), Technology (VO2 Max Analysis, RMR Analysis, Body Composition Analysis), End User (Hospitals, Laboratories, Sports Training Centers, Gyms), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-metabolic-testing-market
  • Blood Culture Test Market, By Method (Conventional/Manual Methods and Automated Methods), Product (Consumables, Instruments and Software and Services), Technology (Culture-Based Technology, Molecular Technologies and Proteomics Technology), Application (Bacteraemia, Fungaemia and Mycobacterial Detection), End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories and Other Laboratories), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-blood-culture-test-market
  • Bioburden Testing Market, By Product (Consumables, Instrument), Test type (Anerobic Count Testing, Mold or Fungi Count Testing, Aerobic Count Testing, Spore Count Testing), Application (Raw Material Testing, Medical Devices Testing, Sterilization Validation Testing, In-process Testing, Equipment Cleaning Validation), End User (Pharmaceutical and Biotechnology Companies, Medical Device Manufacturers, Contract Manufacturing Organizations (CMO), Manufacturers of Food and Beverage and Agricultural Products, Microbial Testing Laboratories), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-bioburden-testing-market
  • Prenatal Genetic Testing Market, By Technology {Diagnostics Methods, Screening Methods}, Screening Techniques (Carrier Screening, Sequential Screening, and Maternal Serum Quad Screening), Diseases (Alzheimer's Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington's Disease, Rare Diseases, Other Diseases), End User (Hospitals, Clinics, Diagnostic Centers), Product (Products, Consumables, Assay Kits, Reagents, Disposables, Instruments, Next Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Ultrasound Devices, Other Instruments, Services) https://www.databridgemarketresearch.com/reports/global-prenatal-genetic-testing-market
  • Sterility Testing Market, By Product (Kits and Reagents, Services and Instruments), Test (Membrane Filtration, Direct Inoculation, Others), Application (Pharmaceutical and Biological Manufacturing, Medical Device Manufacturing, Others), End Users (Pharmaceutical, Biotechnology, Contract Manufacturing Organization), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-sterility-testing-market
  • Pharmaceutical Equipment Testing Market, By Equipment (Gas Permeation Tester, Container Gas Permeability Tester, Permeability Analyzer, Gas Transmission Rate Instrument, Creasing And Stiffness Tester, Package Drop Tester, Moisture Meter, Package Vibration Tester, Texture Analyzer), Services (Container Testing, Container Closure Integrity Testing, Life Testing, Visual Inspection, Functional Testing, Stability Testing, Raw Material Testing, Method Valuation, Microbial Testing, Environmental Monitoring, Physical Chemical Characterization, Batch-Release Testing), End Use (Pharmaceutical Companies, Contract Research Organizations, Government Organization, Research Institutes, Testing Laboratories) https://www.databridgemarketresearch.com/reports/global-pharmaceutical-equipment-testing-market
  • High Blood Pressure Treatment Market, By Type (Systemic Hypertension Drugs, Pulmonary Hypertension Drugs), Drug type (Angiotensin Converting Enzyme (ACE) Inhibitor, Diuretic, Angiotensin II Receptor Blockers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-high-blood-pressure-treatment-market

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com


Tags

Health Screening Health Screening Market Health Screening Market size Health Screening Market share Medical Screening market

Related Links